Aigen Investment Management, LP Axogen, Inc. Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$17.8 - $23.5 $175,953 - $232,297	-9,885 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$17.18 - $22.6 $18,588 - $24,453	-1,082 Reduced 9.87%	9,885 $200,000
Q4 2020 Feb 12, 2021	SELL	$11.5 - $17.96 $108,997 - $170,224	-9,478 Reduced 46.36%	10,967 $196,000
Q3 2020 Nov 06, 2020	SELL	$10.62 - $13.12 $335,443 - $414,408	-31,586 Reduced 60.71%	20,445 $238,000
Q2 2020 Aug 10, 2020	BUY	$7.35 - $10.81 $382,383 - $562,390	52,025 Added 867083.31%	52,031 $481,000
Q1 2020 May 08, 2020	BUY	$8.38 - $17.34 $50 - $104	6 New	6 $0

180

36.4M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $767M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.